We therefore tested the hypothesis that blockade of NCX with the addition of SEA0400 to a cardioplegia solution would limit accumulation of intracellular Ca2+ during ischemia and result in superior recovery of left ventricular (LV) function after reperfusion. The gene discussed is TLX2; the disease is ischemia.